Education
About Us
Working with TipRanks
Follow Us
Oaktree Acquisition Corp. III Life Sciences Class A (OACC)
NASDAQ:OACC
Total Valuation
Oaktree Acquisition Corp. III Life Sciences Class A has a market cap or net worth of $260.58M. The enterprise value is ―.
Market Cap$260.58M
Enterprise Value―
Share Statistics
Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,783,010
Owned by Insiders―
Owned by Institutions55.69%
Financial Efficiency
Oaktree Acquisition Corp. III Life Sciences Class A’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee0.00
Profits Per Employee887.67
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Oaktree Acquisition Corp. III Life Sciences Class A is 53.6. Oaktree Acquisition Corp. III Life Sciences Class A’s PEG ratio is 0.00.
PE Ratio53.6
PS Ratio0.00
PB Ratio1.31
Price to Fair Value1.31
Price to FCF-1.37M
Price to Operating Cash Flow-731.52
PEG Ratio0.00
Income Statement
In the last 12 months, Oaktree Acquisition Corp. III Life Sciences Class A had revenue of 0.00 and earned 2.66K in profits. Earnings per share was 0.05.
Revenue0.00
Gross Profit0.00
Operating Income-703.00
Pretax Income2.66K
Net Income2.66K
EBITDA0.00
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was -278.20K and capital expenditures 0.00, giving a free cash flow of -278.20K billion.
Operating Cash Flow-278.20K
Free Cash Flow-278.20K
Free Cash Flow per Share-0.01
Dividends & Yields
Oaktree Acquisition Corp. III Life Sciences Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change6.23%
50-Day Moving Average10.57
200-Day Moving Average10.40
Relative Strength Index (RSI)48.92
Average Volume (3m)63.92K
Important Dates
Oaktree Acquisition Corp. III Life Sciences Class A upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Oaktree Acquisition Corp. III Life Sciences Class A as a current ratio of 2.14, with Debt / Equity ratio of 0.00%
Current Ratio2.14
Quick Ratio2.14
Debt to Market Cap<0.01
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Oaktree Acquisition Corp. III Life Sciences Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oaktree Acquisition Corp. III Life Sciences Class A EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -1.36M.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow-1.36M
EV to Operating Cash Flow-1.36M
Balance Sheet
Oaktree Acquisition Corp. III Life Sciences Class A has ― in cash and marketable securities with $0.00 in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt$0.00
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$7.63
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Oaktree Acquisition Corp. III Life Sciences Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―